Jesus Gonzalez-Rubio

Dr. Jesus Gonzalez-Rubio

Adjunct Professor University of Castilla La Mancha Albacete, Spain
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JGJesus Gonzalez-Rubio
Jesus Gonzalez-Rubio
CNCarmen Navarro-Lopez
Carmen Navarro-Lopez
ELElena Lopez-Najera
Elena Lopez-Najera
ALAna Lopez-Najera
Ana Lopez-Najera
LJLydia Jimenez-Diaz
Lydia Jimenez-Diaz
ALAlberto Nájera López
Alberto Nájera López
SARS-CoV-2 is a new coronavirus that has caused a worldwide pandemic. It causes severe acute respiratory syndrome (COVID-19), which is fatal in many cases, and is characterized by a cytokine release syndrome (CRS). Great efforts are currently being made to block the signal transduction pathway of pro-inflammatory cytokines in order to control this “cytokine storm” and rescue severely affected patients. Consequently, possible treatments for cytokine-mediated hyperinflammation, preferably within approved safe therapies, are urgently being researched to reduce rising mortality. One approach to inhibit proinflammatory cytokine release is to activate the cholinergic anti-inflammatory pathway through nicotinic acetylcholine receptors (α7nAchR). Nicotine, an exogenous α7nAchR agonist, is clinically used in ulcerative colitis to counteract inflammation. We have found epidemiological evidence, based on recent clinical SARS-CoV-2 studies in China, that suggest that smokers are statistically less likely to be hospitalized. In conclusion, our hypothesis proposes that nicotine could constitute a novel potential CRS therapy in severe SARS-CoV-2 patients.


JGJesus Gonzalez-Rubio
Jesus Gonzalez-Rubio
CNCarmen Navarro-López
Carmen Navarro-López
ELElena López-Nájera
Elena López-Nájera
ALAna López-Nájera
Ana López-Nájera
LJLydia Jimenez-Diaz
Lydia Jimenez-Diaz
ALAlberto Nájera López
Alberto Nájera López
SARS-CoV-2 is a new coronavirus that has caused a worldwide pandemic. It produces severe acute respiratory disease (COVID-19), which is fatal in many cases, characterised by the cytokine release syndrome (CRS). According to the World Health Organization, those who smoke are likely to be more vulnerable to infection. Here, in order to clarify the epidemiologic relationship between smoking and COVID-19, we present a systematic literature review until 28th April 2020 and a meta-analysis. We included 18 recent COVID-19 clinical and epidemiological studies based on smoking patient status from 720 initial studies in China, the USA, and Italy. The percentage of hospitalised current smokers was 7.7% (95% CI: 6.9–8.4) in China, 2.3% (95% CI: 1.7–2.9) in the USA and 7.6% (95% CI: 4.2–11.0) in Italy. These percentages were compared to the smoking prevalence of each country and statistically significant differences were found in them all (p < 0.0001). By means of the meta-analysis, we offer epidemiological evidence showing that smokers were statistically less likely to be hospitalised (OR = 0.18, 95% CI: 0.14–0.23, p < 0.01). In conclusion, the analysis of data from 18 studies shows a much lower percentage of hospitalised current smokers than expected. As more studies become available, this trend should be checked to obtain conclusive results and to explore, where appropriate, the underlying mechanism of the severe progression and adverse outcomes of COVID-19.

1 August 2016 in Environmental Research
Verified
Journal Article
Closed access
JGJesus Gonzalez-Rubio
Jesus Gonzalez-Rubio
ALAlberto Nájera López
Alberto Nájera López
Enrique ArribasEnrique Arribas
Enrique Arribas

Raquel Ramirez-VazquezRaquel Ramirez-Vazquez
Raquel Ramirez-Vazquez
JGJesus Gonzalez-Rubio
Jesus Gonzalez-Rubio
IEIsabel Escobar
Isabel Escobar
Carmen del Pilar Suárez RodríguezCarmen del Pilar Suárez Rodríguez
Carmen del Pilar Suárez Rodríguez
Enrique ArribasEnrique Arribas
Enrique Arribas
In recent years, personal exposure to Radiofrequency Electromagnetic Fields (RF-EMF) has substantially increased, and most studies about RF-EMF with volunteers have been developed in Europe. To the best of our knowledge, this is the first study carried out in Mexico with personal exposimeters. The main objective was to measure personal exposure to RF-EMF from Wireless Fidelity or wireless Internet connection (Wi-Fi) frequency bands in Tamazunchale, San Luis Potosi, Mexico, to compare results with maximum levels permitted by international recommendations and to find if there are differences in the microenvironments subject to measurements. The study was conducted with 63 volunteers in different microenvironments: home, workplace, outside, schools, travel, and shopping. The mean minimum values registered were 146.5 μW/m2 in travel from the Wi-Fi 2G band and 116.8 μW/m2 at home from the Wi-Fi 5G band, and the maximum values registered were 499.7 μW/m2 and 264.9 μW/m2 at the workplace for the Wi-Fi 2G band and the Wi-Fi 5G band, respectively. In addition, by time period and type of day, minimum values were registered at nighttime, these values being 129.4 μW/m2 and 93.9 μW/m2, and maximum values were registered in the daytime, these values being 303.1 μW/m2 and 168.3 μW/m2 for the Wi-Fi 2G and Wi-Fi 5G bands, respectively. In no case, values exceeded limits established by the International Commission on Non-Ionizing Radiation Protection (ICNIRP). Of the study participants (n = 63), a subgroup (n = 35) answered a survey on risk perception. According to these results, the Tamazunchale (Mexico) population is worried about this situation in comparison with several European cities; however, the risk perception changes when they are informed about the results for the study.

Raquel Ramirez-VazquezRaquel Ramirez-Vazquez
Raquel Ramirez-Vazquez
SASameer Arabasi
Sameer Arabasi
HAHussein Al-Taani
Hussein Al-Taani
SSSuhad Sbeih
Suhad Sbeih
JGJesus Gonzalez-Rubio
Jesus Gonzalez-Rubio
Enrique ArribasEnrique Arribas
Enrique Arribas
In the last two decades, due to the development of the information society, the massive increase in the use of information technologies, including the connection and communication of multiple electronic devices, highlighting Wi-Fi networks, as well as the emerging technological advances of 4G and 5G (new-generation mobile phones that will use 5G), have caused a significant increase in the personal exposure to Radiofrequency Electromagnetic Fields (RF-EMF), and as a consequence, increasing discussions about the possible adverse health effects. The main objective of this study was to measure the personal exposure to radiofrequency electromagnetic fields from the Wi-Fi in the university area of German Jordanian University (GJU) and prepare georeferenced maps of the registered intensity levels and to compare them with the basic international restrictions. Spot measurements were made outside the university area at German Jordanian University. Measurements were made in the whole university area and around two buildings. Two Satimo EME SPY 140 (Brest, France) personal exposimeters were used, and the measurements were performed in the morning and afternoon, and on weekends and weekdays. The total average personal exposure to RF-EMF from the Wi-Fi band registered in the three study areas and in the four days measured was 28.82 μW/m2. The average total exposure from the Wi-Fi band registered in the ten measured points of the university area of GJU was 22.97 μW/m2, the one registered in the eight measured points of building H was 34.48 μW/m2, and the one registered in the eight points of building C was 29.00 μW/m2. The maximum average values registered in the campus of GJU are below the guidelines allowed by International Commission on Non-ionizing Radiation Protection (ICNIRP). The measurement protocol used in this work has been applied in measurements already carried out in Spain and Mexico, and it is applicable in university areas of other countries.